En Es
Categories

Technopath Clinical Diagnostics

Technopath Clinical Diagnostics develops and manufactures total quality control (QC) solutions for clinical laboratories and has launched the IVD industry’s first truly consolidated Immunochemistry QC materials. Technopath’s core product offering is focused on making the QC process simpler and more efficient for laboratorie ...
Products Covid-19NewsSummary
Close

Covid-19 Technopath Clinical Diagnostics

Clinical Laboratory

Third-Party Quality Control for IgM Antibodies to SARS-C0V-2
Multichem ID-COVID19 G

The Multichem ID-COVID19 G is a third-party quality control (QC) for IgG antibodies to SARS-C0V-2 with the QC samples specifically optimized and validated to match assays commonly used for COVID-19 disease testing. The product is suitable for most platforms including Abbott, Roche and Siemens, and is delivered in a choice of two configurations.
More details

Third-Party Quality Control for IgM Antibodies to SARS-C0V-2
Multichem ID-COVID19 M

The Multichem ID-COVID19 M is a third-party quality control (QC) for IgM antibodies to SARS-C0V-2 with the QC samples specifically optimized and validated to match assays commonly used for COVID-19 disease testing. It helps assess the precision of COVID-19 assays and satisfies the regulatory guidelines for use of independent controls.
More details

Negative Third-Party QC for IgM Antibodies to SARS-C0V-2
Multichem ID-COVID19Neg

The Multichem ID-COVID19Neg is a negative third-party quality control for IgG and IgM antibodies to SARS-C0V-2 with the QC samples specifically optimized and validated to match assays commonly used for COVID-19 disease testing. The product is suitable for most platforms including Abbott, Roche and Siemens, and is delivered in a choice of two configurations.
More details
Close

News of Technopath Clinical Diagnostics

LGC Acquires Technopath Clinical Diagnostics to Strengthen Position in Clinical Diagnostics QC Market

03 Feb 2021
LGC Acquires Technopath Clinical Diagnostics to Strengthen Position in Clinical Diagnostics QC Market
 LGC (Middlesex, UK) has acquired Technopath Clinical Diagnostics (Tipperary, Ireland), a developer and manufacturer of quality control (QC) solutions for clinical laboratories.
Read More
Close

About Technopath Clinical Diagnostics

Technopath Clinical Diagnostics develops and manufactures total quality control (QC) solutions for clinical laboratories and has launched the IVD industry’s first truly consolidated Immunochemistry QC materials. Technopath’s core product offering is focused on making the QC process simpler and more efficient for laboratories and more accurate and precise for patients by designing products that are targeted at clinical decision points and consolidate the number of QC materials required by the laboratory while automating the reporting and data management process.
FaceBook Twitter Google+ Linked in
Negative Third-Party QC for IgM Antibodies to SARS-C0V-2

Negative Third-Party QC for IgM Antibodies to SARS-C0V-2

Model: Multichem ID-COVID19Neg
Request Information

Description:

The Multichem ID-COVID19Neg is a negative third-party quality control for IgG and IgM antibodies to SARS-C0V-2 with the QC samples specifically optimized and validated to match assays commonly used for COVID-19 disease testing. The product is suitable for most platforms including Abbott, Roche and Siemens, and is delivered in a choice of two configurations.

Features

Features

• 36 month closed tube stability at 2°C to 8°C
• 30 day open tube stability at 2°C to 8°C
• Ready-to-use liquid stable
• Third party independent quality control Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Technopath Clinical Diagnostics (Negative Third-Party QC for IgM Antibodies to SARS-C0V-2)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions